| Old Articles: <Older 31821-31830 Newer> |
 |
The Motley Fool August 26, 2008 Rick Aristotle Munarriz |
Amazon Gets Social Booklovers have another reason to warm up to Amazon.com. The world's leading online retailer is buying Shelfari, a social network for reading fans, for undisclosed terms.  |
The Motley Fool August 26, 2008 Tim Beyers |
How to Make Airlines Profitable Again Here's the simple truth of the airline industry: Every carrier -- and I mean every carrier -- needs to raise fares.  |
The Motley Fool August 26, 2008 Todd Wenning |
5 Stocks Caught in a Bullish Stampede Here are five stocks rising on unusual trading volume. It's worth taking a look to see what's piqued the market's interest in them.  |
The Motley Fool August 26, 2008 Rick Aristotle Munarriz |
Discounted Kindles Tell a Story Just three months after Amazon.com shaved $40 off its Kindle e-book reader, it's back with a promotion to cut another $100 off the retail price.  |
The Motley Fool August 26, 2008 Brian Orelli |
Baxter Ready to Sop Up Additional Revenue The health-care giant licenses a surgical sponge in clinical development.  |
The Motley Fool August 25, 2008 Rich Smith |
Hey! Who's Flying This Thing? Part 3 It's time to catch up with the latest developments regarding unmanned aerial vehicles.  |
The Motley Fool August 25, 2008 Toby Shute |
Precision Lands Its Prey Persistence pays off in the driller's bid for rival Grey Wolf.  |
The Motley Fool August 25, 2008 David Lee Smith |
BHP-Rio Tinto Merger Rattled The proposed takeover of London-based mineral miner Rio Tinto by its larger Australian rival BHP Billiton has taken a couple of direct hits in the past few days, leaving the megamerger's future in dire doubt.  |
The Motley Fool August 25, 2008 Ilan Moscovitz |
The Next 2 Dividend Blowups? Nearly 100 companies cut their dividends during the second quarter, the biggest quarterly decline since 1991. Who might be next?  |
The Motley Fool August 25, 2008 Rich Duprey |
Lipitor Marketing Raises Blood Pressure Pfizer continues affinity-group marketing of its best-selling cholesterol drug Lipitor.  |
| <Older 31821-31830 Newer> Return to current articles. |